Actively Recruiting
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
Led by Assiut University · Updated on 2021-08-12
20
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand the clinical characteristics and risk factors of children suffering from inflammatory bowel disease (IBD) at Assiut University Children Hospital. It focuses on patients under 18 years old with a confirmed diagnosis of IBD to gain insights into symptoms and contributing factors related to this condition. All participating children will undergo detailed medical history collection, including family history and gastrointestinal symptoms such as rectal bleeding, diarrhea, abdominal pain, nausea, and appetite loss. A thorough physical examination covering general health, chest, heart, abdomen, and neurological status will be performed. Laboratory tests like fecal calprotectin, CRP, CBC, and ESR will be conducted, alongside endoscopic examinations and histological study of tissue biopsies taken during endoscopy. Children's involvement includes providing medical history and undergoing physical examinations and lab tests during their hospital stay. Researchers will measure clinical features and risk factors of IBD over a 6-month period. The study will monitor these factors carefully to better understand the disease in children. Participation will last as long as needed to complete these assessments and investigations, with no interventional treatments administered as part of the study.
CONDITIONS
Brief Title
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged less than 18 years with a confirmed diagnosis of IBD.
You will not qualify if you...
- Children with colitis other than IBD.
- Children with systemic diseases affecting the gastrointestinal tract.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months
Participants undergo history taking, physical examinations, and laboratory and endoscopic investigations to assess inflammatory bowel disease characteristics.
Initial assessment visit and follow-up evaluations as needed
Duration - 6 months
Participants are observed over time to evaluate clinical characteristics and risk factors of inflammatory bowel disease.
Regular visits during the 6-month observation period
Trial Site Locations
Total: 1 location
1
Christine zaghloul noos
Asyut, Egypt, 23123
Actively Recruiting
Research Team
C
Christine Zaghloul, Resident
M
Maher Mokhtar, Professor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here